Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Abacavir + Lamivudine + Dolutegravir
Triumeq
Routinely available
SMC (1009/14)
11/11/2015
Indication
For the treatment of Human Immunodeficiency Virus (HIV) infected adults and adolescents above 12 years of age weighing at least 40 kg.
Therapeutic Area
Infections
Status Description
Routinely available
Formulation
50mg/600mg/300mg film-coated tablets
Comments
November 2015 - Included on the Additional list, Specialist use only, for the indication in question.
Link to Advice
Advice Published
08/12/2014
SMC Submission Type
Abbreviated
SMC Status
Accepted